BlackRock Inc. grew its stake in Stericycle Inc (NASDAQ:SRCL) by 2.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,375,722 shares of the business services provider’s stock after purchasing an additional 133,660 shares during the period. BlackRock Inc. owned approximately 6.26% of Stericycle worth $350,980,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of SRCL. Whittier Trust Co. raised its holdings in shares of Stericycle by 362.6% in the second quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock worth $129,000 after buying an additional 852 shares during the period. Federated Investors Inc. PA raised its holdings in shares of Stericycle by 129.5% in the first quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock worth $122,000 after buying an additional 1,178 shares during the period. Dupont Capital Management Corp raised its holdings in shares of Stericycle by 102.2% in the second quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock worth $136,000 after buying an additional 1,056 shares during the period. Intact Investment Management Inc. purchased a new stake in shares of Stericycle in the second quarter worth approximately $202,000. Finally, Diversified Trust Co purchased a new stake in shares of Stericycle in the second quarter worth approximately $220,000. 95.46% of the stock is owned by institutional investors and hedge funds.
Several brokerages have recently weighed in on SRCL. Jefferies Financial Group set a $75.00 price target on Stericycle and gave the stock a “buy” rating in a report on Thursday, August 2nd. BidaskClub upgraded Stericycle from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 31st. Zacks Investment Research downgraded Stericycle from a “buy” rating to a “hold” rating in a report on Monday, July 16th. BMO Capital Markets reiterated a “hold” rating and issued a $71.00 price target on shares of Stericycle in a report on Thursday, July 12th. Finally, Barrington Research reiterated a “buy” rating on shares of Stericycle in a report on Friday, June 1st. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $71.71.
In other Stericycle news, Director Mark C. Miller sold 65,314 shares of the firm’s stock in a transaction on Thursday, July 5th. The stock was sold at an average price of $65.08, for a total transaction of $4,250,635.12. Following the transaction, the director now directly owns 224,052 shares in the company, valued at approximately $14,581,304.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mark C. Miller sold 95,227 shares of the firm’s stock in a transaction on Monday, July 2nd. The stock was sold at an average price of $65.05, for a total value of $6,194,516.35. Following the transaction, the director now owns 257,488 shares in the company, valued at $16,749,594.40. The disclosure for this sale can be found here. Insiders have sold a total of 170,541 shares of company stock worth $11,148,901 over the last 90 days. 3.50% of the stock is currently owned by company insiders.
Shares of NASDAQ SRCL opened at $60.92 on Friday. The company has a market capitalization of $5.26 billion, a PE ratio of 14.04, a price-to-earnings-growth ratio of 1.42 and a beta of 0.36. Stericycle Inc has a fifty-two week low of $56.64 and a fifty-two week high of $76.73. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.87.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, August 2nd. The business services provider reported $1.17 EPS for the quarter, topping the consensus estimate of $1.13 by $0.04. The company had revenue of $883.30 million for the quarter, compared to the consensus estimate of $896.62 million. Stericycle had a return on equity of 14.04% and a net margin of 5.03%. Stericycle’s quarterly revenue was down 3.7% on a year-over-year basis. During the same period last year, the business posted $1.15 EPS. equities research analysts anticipate that Stericycle Inc will post 4.47 earnings per share for the current year.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
See Also: How is a Moving Average Calculated?
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.